Clinical Trials Sponsored by Situs Cancer Research Center

Total 9760 results

H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy

Breast Cancer

United States
Benaroya Research Institute
Fred Hutchinson Cancer Center; Virginia Mason Hospital/Medical Center

Suspended

Pilot Study of Biomarkers for Radiation Therapy

Cancer

United States
Fred Hutchinson Cancer Center
Fox Chase Cancer Center; City of Hope Medical Center; Stanford University; Cedars-Sinai... and other collaborators

Completed

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

Epithelial Ovarian Cancer

United States
Jonsson Comprehensive Cancer Center
Tobacco Related Disease Research Program

Recruiting

Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups

Colorectal Carcinoma

United States
Technische Universität Dresden
German Cancer Research Center; KKS Dresden

Not yet recruiting

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula (XandTX)

Periampullary Cancer | Postoperative Pancreatic Fistula

Germany
Fred Hutchinson Cancer Center
Kenya Medical Research Institute; Jhpiego

Recruiting

Pharmacy-based PrEP Delivery in Kenya

Hiv

Kenya
H. Lee Moffitt Cancer Center and Research Institute
GlaxoSmithKline

Recruiting

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

Penile Carcinoma

United States
Cedars-Sinai Medical Center
California Breast Cancer Research Program

Recruiting

Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women

Health Knowledge, Attitudes, Practice | Breast Cancer Female | Health Disparities | Cancer Screening

United States
H. Lee Moffitt Cancer Center and Research Institute
BeiGene

Recruiting

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

Prostate Cancer | Stage IV Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Active, not recruiting

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

Renal Cell Carcinoma Stage IV

United States
Vanderbilt-Ingram Cancer Center
Human Animal Bond Research Institute

Completed

Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents

Advanced Cancer | Relapsed Cancer | Refractory Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca

Terminated

Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer

Breast Cancer | Hormone Receptor Positive Tumor

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

Breast Cancer | Breast Cancer - Female | Breast Cancer - Male

United States
University of Hawaii
University of Hawaii Cancer Research Center

Terminated

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Graft Versus Host Disease | GVHD

United States
H. Lee Moffitt Cancer Center and Research Institute
Bayer

Completed

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Prostate Cancer | Prostate Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)

Graft-Versus-Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Terminated

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Liver Cancer

United States
University of Hawaii
University of Hawaii Cancer Research Center

Completed

Goal Setting and Lifestyle (GSDB)

Physical Activity | Diet

United States
German Cancer Research Center
Mukoviszidose Institut gGmbH; Heidelberg University

Completed

Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)

Cystic Fibrosis | Lung Disease

Germany
Rachel Sanborn
AstraZeneca; Providence Cancer Center, Earle A. Chiles Research Institute

Active, not recruiting

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Lung Cancer | Non-small Cell Carcinoma

United States
Heidelberg University
University of Heidelberg Medical Center; German Cancer Research Center; National... and other collaborators

Completed

Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease

Breast Cancer | Colorectal Cancer | Prostate Cancer | Physicians | Nurses
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Andy Hill Cancer Research Endowment (CARE)...

Not yet recruiting

Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials (GUIDE)

Breast Carcinoma | Digestive System Carcinoma | Genitourinary System Carcinoma

United States
Ralph Hauke
Prometheus Laboratories; Nebraska Cancer Specialists; Midwest Cancer Center-Legacy

Terminated

Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma

Melanoma

United States
Boston Medical Center
Patient-Centered Outcomes Research Institute; American Cancer Society, Inc.

Completed

Socio-legal Services for Underserved Populations Through Patient Navigation to Optimize Resources During Treatment (SUPPORT)

Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Recruiting

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Melanoma Stage IV | BRAF V600 Mutation | Melanoma Stage III

United States
Technische Universität Dresden
German Cancer Research Center; KKS Dresden

Recruiting

Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer (ARMANI)

Colorectal Liver Metastasis

Germany
H. Lee Moffitt Cancer Center and Research Institute
Amgen

Active, not recruiting

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Breast Cancer | Invasive Breast Carcinoma | Invasive Ductal Breast Carcinoma | Ductal Carcinoma

United States
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Active, not recruiting

Tumor-specific T Cells in Lung Cancer

Non-small Cell Lung Cancer

Germany
H. Lee Moffitt Cancer Center and Research Institute
Exelixis

Completed

Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma

Melanoma

United States
Ludwig Institute for Cancer Research
Radboud University Medical Center

Completed

Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer

Metastatic Renal Cell Carcinoma

Netherlands
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca

Terminated

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

Bladder Cancer | Carcinoma in Situ of Bladder

United States
University Hospital Heidelberg
German Cancer Research Center; Heidelberg University

Completed

Immune Boost In Non-Small Cell Lung Cancer (RadImmune)

Non-small Cell Lung Cancer

Germany
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
Bayer

Completed

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

Cancer of the Bile Duct

United States
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center

Terminated

A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy (MIMIG)

Neoplasms | Lung Diseases | Neoplasms by Site | Lung Neoplasms | Thoracic Neoplasms

United States
H. Lee Moffitt Cancer Center and Research Institute
Bayer

Completed

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

Cholangiocarcinoma | Gastrointestinal Tumor | Gall Bladder Carcinoma | Biliary Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Completed

Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)

Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)

United States
Cedars-Sinai Medical Center
California Breast Cancer Research Program

Terminated

STOP Heart Disease in Breast Cancer Survivors Trial (STOP)

Breast Cancer | Heart Disease | Cardiotoxicity | Myocardial Dysfunction

United States
H. Lee Moffitt Cancer Center and Research Institute
Sanofi

Terminated

Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery

Pancreatic Neoplasms

United States
H. Lee Moffitt Cancer Center and Research Institute
GlaxoSmithKline

Completed

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

Cancer Cachexia

United States
H. Lee Moffitt Cancer Center and Research Institute
Sanofi

Terminated

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

Lung Cancer

United States
M.D. Anderson Cancer Center
Flight Attendant Medical Research Institute

Completed

Markers of Response to Intravesical Bladder Cancer Therapy

Bladder Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Bayer

Completed

Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer

Rectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Completed

Yoga for Aromatase Inhibitor-associated Joint Pain

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Completed

Facts and Attitudes About Clinical Trials (FACT)

Cancer | Neoplasm

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Terminated

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Neuroendocrine Carcinoma

United States

Clinical Trials Sponsored by Situs Cancer Research Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations